DAAN GENE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.2 CNY | +3.00% |
|
-3.61% | -25.62% |
| Apr. 29 | Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 26 | Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Da An Gene Co., Ltd. specializes in the development, manufacture and marketing of molecular diagnosis products for infectious and epidemic diseases. The group offers real-time polymerase chain reaction instruments (QPCR), immunological products, screening systems for cervical cancer, sequencing tools, blood collection tubes and food safety products.
Sector
Pharmaceuticals
Calendar
2024-05-15
- Extraordinary Shareholders Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -25.62% | 1.36B | |
| -17.11% | 57.84M |
- Stock Market
- Equities
- 002030 Stock
- News Daan Gene Co., Ltd.
- Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19